[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

ANI Pharma Inc (ANIP)

ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,783,705
  • Shares Outstanding, K 22,414
  • Annual Sales, $ 883,370 K
  • Annual Income, $ 78,340 K
  • EBIT $ 213 M
  • EBITDA $ 305 M
  • 60-Month Beta 0.46
  • Price/Sales 2.05
  • Price/Cash Flow 8.00
  • Price/Book 3.17

Options Overview Details

View History
  • Implied Volatility 39.63% (-2.78%)
  • Historical Volatility 32.11%
  • IV Percentile 22%
  • IV Rank 17.46%
  • IV High 73.85% on 07/24/25
  • IV Low 32.40% on 09/22/25
  • Expected Move (DTE 34) 5.95 (7.48%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 2
  • Volume Avg (30-Day) 128
  • Put/Call OI Ratio 1.80
  • Today's Open Interest 3,477
  • Open Int (30-Day) 3,320
  • Expected Range 73.63 to 85.53

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $1.77
  • Number of Estimates 4
  • High Estimate $1.93
  • Low Estimate $1.61
  • Prior Year $1.38
  • Growth Rate Est. (year over year) +28.26%

Price Performance

See More
Period Period Low Period High Performance
1-Month
75.88 +4.88%
on 04/15/26
87.76 -9.32%
on 05/08/26
+1.29 (+1.65%)
since 04/14/26
3-Month
70.15 +13.44%
on 03/13/26
87.76 -9.32%
on 05/08/26
+2.22 (+2.87%)
since 02/13/26
52-Week
56.71 +40.33%
on 05/23/25
99.50 -20.02%
on 09/10/25
+19.21 (+31.82%)
since 05/14/25

Most Recent Stories

More News
2 Profitable Stocks with Competitive Advantages and 1 Facing Headwinds

2 Profitable Stocks with Competitive Advantages and 1 Facing Headwinds

MYRG : 454.56 (-3.91%)
ANIP : 79.28 (-0.38%)
BGS : 4.28 (+0.23%)
ANI Pharmaceuticals Q1 Earnings Call Highlights

ANI Pharmaceuticals (NASDAQ:ANIP) reported first-quarter 2026 results that management said show continued progress in its effort to “accelerat[e] our transformation into a leading rare disease company,”...

ANIP : 79.28 (-0.38%)
ANI Pharmaceuticals (NASDAQ:ANIP) Delivers Impressive Q1 CY2026, Stock Soars

ANI Pharmaceuticals (NASDAQ:ANIP) Delivers Impressive Q1 CY2026, Stock Soars

ANIP : 79.28 (-0.38%)
ANI: Q1 Earnings Snapshot

ANI: Q1 Earnings Snapshot

ANIP : 79.28 (-0.38%)
ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial Guidance

Quarterly net revenues of $237.5 million, an increase of 20.5% year-over-year Purified Cortrophin ® Gel net revenues of $75.1 million, an increase of 42.1% year-over-year Quarterly...

ANIP : 79.28 (-0.38%)
ANI Pharmaceuticals Reports Today but the Cortrophin Reverification Question Looms Larger

Barchart Research What to Expect from ANIP Earnings ANIP Generated May 7, 2026 Current Price $83.91 EPS Estimate $$0.95 Consensus Rating Strong Buy Average Move 7.34% ANI Pharmaceuticals Reports Today...

ANIP : 79.28 (-0.38%)
ANI Pharmaceuticals (ANIP) Q1 Earnings: What To Expect

ANI Pharmaceuticals (ANIP) Q1 Earnings: What To Expect

ANIP : 79.28 (-0.38%)
ANI Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 8, 2026, at 8:00 a.m. ET

PRINCETON, N.J., April 24, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that the Company will release its first quarter 2026 financial results...

ANIP : 79.28 (-0.38%)
ANI Pharmaceuticals Announces the FDA Approval and Launch of Pimozide Tablets with 180 Day CGT Exclusivity

PRINCETON, N.J., April 20, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Pimozide Tablets 1 mg and 2 mg. ANI’s Pimozide Tablets...

ANIP : 79.28 (-0.38%)
1 Cash-Producing Stock with Promising Prospects and 2 Facing Challenges

1 Cash-Producing Stock with Promising Prospects and 2 Facing Challenges

ANIP : 79.28 (-0.38%)
SNX : 229.92 (-1.90%)
EVER : 17.47 (+0.58%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

Relative Strength just crossed below 50%. The market is indicating support for a bearish trend.

See More Share

Business Summary

ANI Pharmaceuticals, Inc. is a specialty pharmaceutical company. It engaged in developing, manufacturing and marketing branded and generic prescription pharmaceuticals. The company offers liquid, powder, oral solid dose, cough/cold products, antacids, laxatives, stomach remedies as well as hydrocortisone...

See More

Key Turning Points

3rd Resistance Point 83.82
2nd Resistance Point 82.71
1st Resistance Point 81.14
Last Price 79.28
1st Support Level 78.47
2nd Support Level 77.36
3rd Support Level 75.80

See More

52-Week High 99.50
Fibonacci 61.8% 83.15
Last Price 79.28
Fibonacci 50% 78.10
Fibonacci 38.2% 73.06
52-Week Low 56.71

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.